Our Services
Neurology & Oncology
Brain Tumours
Precision-guided stereotactic radiosurgery (SRS) and fractionated radiotherapy for primary brain tumours, metastases, and benign lesions — delivering therapeutic doses with sub-millimetre accuracy while protecting eloquent cortex.
Stereotactic Radiosurgery (SRS)
Single-fraction or hypofractionated treatment for brain metastases, meningiomas, and acoustic neuromas.
MRT / VMAT Planning
Conformal dose sculpting around critical structures — optic nerves, brainstem, hippocampus.
Whole Brain RT with Hippocampal Avoidance
Neurocognitive preservation in patients receiving prophylactic or therapeutic whole-brain irradiation.
Advanced Radiation Therapy
Head & Neck Cancers
Advanced image-guided radiotherapy for oral, oropharyngeal, laryngeal, hypopharyngeal, and thyroid cancers — maximizing locoregional control while preserving swallowing, voice, and quality of life through precise dose sculpting.
IMRT / Rapid Arc VMAT
Dose painting with parotid gland and spinal cord sparing to reduce xerostomia and neurological toxicity.
Concurrent Chemoradiation (CCRT)
Weekly or 3-weekly cisplatin with definitive or adjuvant RT for advanced-stage disease.
Re-irradiation Planning
Careful cumulative dose assessment with BED calculations for recurrent or second primary tumours.
Supportive Care Integration
Nutrition counselling, mucosal care, and swallowing therapy coordinated throughout treatment.
SBRT · Stereotactic Body RT
Lung & Liver Tumours
Stereotactic Body Radiotherapy (SBRT) delivers ablative-dose radiation in a small number of fractions with extreme precision — ideal for early-stage lung cancer, oligometastatic disease, and unresectable hepatocellular carcinoma.
4D-CT Respiratory Gating
Motion-encompassing ITV delineation to track tumour throughout the breathing cycle — reducing margins and protecting healthy lung.
DIBH / Active Breathing Control
Deep inspiration breath-hold technique for liver SBRT, minimising hepatic dome movement during beam delivery.
Online CBCT Image Guidance
Daily imaging with couch corrections for sub-millimetre positional accuracy before every fraction.
Esophageal . Rectal
Esophageal & Rectal Cancers
Specialized multimodality radiotherapy for gastrointestinal cancers — combining neoadjuvant chemoradiation, definitive CRT, and organ-preservation strategies with meticulous planning to protect bowel, bladder, and spinal cord.
Neoadjuvant CRT (CROSS Protocol)
Weekly carboplatin + paclitaxel with 41.4 Gy / 23 fractions prior to esophagectomy — improving R0 resection rates and pCR.
Definitive CRT for Esophageal Cancer
50–50.4 Gy with concurrent cisplatin/5-FU for inoperable or patient-choice organ preservation, particularly in SCC.
Rectal SCRT & Long-Course CRT
25 Gy / 5 fx (Swedish protocol) or 45–50.4 Gy CRT (German CAO/ARO) — watch-and-wait strategy for clinical complete responders.
Total Neoadjuvant Therapy (TNT)
RAPIDO and PRODIGE-23 informed consolidation chemotherapy + CRT for high-risk rectal cancer to maximise organ preservation.
